Marked synergism between vasopressin and angiotensin II in a human isolated artery

被引:13
作者
Hidaka, T [1 ]
Tsuneyoshi, I
Boyle, WA
Onomoto, M
Yonetani, S
Hamasaki, J
Katai, R
Kanmura, Y
机构
[1] Kagoshima Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Kagoshima 890, Japan
[2] Washington Univ, Sch Med, Dept Anesthesiol, Div Adult Crit Care, St Louis, MO 63110 USA
关键词
angiotensin II; vasopressin; tachyphylaxis; human vascular smooth muscle; hemorrhagic shock; gastroepiploic artery;
D O I
10.1097/01.CCM.0000186759.13325.DC
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Objective: To determine the direct contractile effects of angiotensin II (AII) and vasopressin (VP), and the effects of combinations of these agonists, in human isolated gastroepiploic arteries in vitro. Design: Laboratory and clinical investigation. Setting: University laboratory and hospital. Subjects: Ring segments were prepared from gastroepiploic arteries obtained from 57 patients undergoing gastrectomy. Blood samples were obtained from ten patients after severe hemorrhage and from five healthy volunteers. Interventions: Mechanical activity in the rings was assessed using a strain gauge. Plasma concentrations of AII and VP in the blood samples were measured using radioimmunoassay kits. Measurements and Main Results: Both AII (1 or 10 ng/mL) and VP (100 or 500 pg/mL) produced concentration-dependent contractions in the rings. However, whereas VP produced reproducible sustained contractions, the contractile responses induced by multiple applications of AII showed marked desensitization (i.e., tachyphylaxis). Indeed, by the sixth application of either 1 ng/mL AII or 10 ng/mL AII, the contractile responses were <20% of the initial (control) response. During applications of AII after the sixth, the co-application of a low concentration of VP (100 pg/mL) fully restored the contractile response to AII in a clearly more-than-additive fashion. Similarly, the tachyphylaxis seen on AII application alone did not occur with repeated applications of an AII+norepinephrine mixture. In patients who had experienced hemorrhage, there were marked elevations of both AII and VP plasma concentrations, with values as high as 2.2 ng/mL and 550 pg/mL, respectively. Conclusion: These results indicate that there is a powerful synergism between the contractile effects of low-dose VP and AII in this human isolated artery. Moreover, the elevations of plasma AII and VP levels during hemorrhage suggest that this synergism may be both physiologically and clinically important in optimizing vasoconstriction and maintaining blood pressure in such critical states.
引用
收藏
页码:2613 / 2620
页数:8
相关论文
共 34 条
[1]
ANDERSON KM, 1993, AM J PHYSIOL, V264, P179
[2]
BOND RF, 1985, FED PROC, V44, P281
[3]
CARAMELO C, 1988, AM J CARDIOL, V62, pG47
[4]
INTERACTION OF ARGININE VASOPRESSIN AND ANGIOTENSIN-II ON CA-2+ IN VASCULAR SMOOTH-MUSCLE CELLS [J].
CARAMELO, C ;
OKADA, K ;
TSAI, P ;
LINAS, SL ;
SCHRIER, RW .
KIDNEY INTERNATIONAL, 1990, 38 (01) :47-54
[5]
INFLUENCE OF CHRONIC ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON ANESTHETIC INDUCTION [J].
CORIAT, P ;
RICHER, C ;
DOURAKI, T ;
GOMEZ, C ;
HENDRICKS, K ;
GIUDICELLI, JF ;
VIARS, P .
ANESTHESIOLOGY, 1994, 81 (02) :299-307
[6]
Local nitric oxide release does not affect tachyphylaxis to angiotensin II in dorsal hand veins in man in the presence of prostaglandin synthesis inhibition [J].
de Haas, SL ;
Wilkinson, IB ;
Boyd, JL ;
Webb, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (02) :193-195
[7]
Angiotensin II signaling in vascular smooth muscle - New concepts [J].
Griendling, KK ;
UshioFukai, M ;
Lassegue, B ;
Alexander, RW .
HYPERTENSION, 1997, 29 (01) :366-373
[8]
The effects of vasopressin on endotoxin-induced attenuation of contractile responses in human gastroepiploic arteries in vitro [J].
Hamu, Y ;
Kanmura, Y ;
Tsuneyoshi, I ;
Yoshimura, N .
ANESTHESIA AND ANALGESIA, 1999, 88 (03) :542-548
[9]
Angiotensin II in human veins: Development of rapid desensitization and effect of indomethacin [J].
Harada, K ;
Ohmori, M ;
Kitoh, Y ;
Sugimoto, K ;
Fujimura, A .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (12) :959-963
[10]
HENRION D, 1992, J PHARMACOL EXP THER, V261, P835